Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGEN

Agenus (AGEN)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AGEN
DateTimeSourceHeadlineSymbolCompany
10/12/20218:30AMGlobeNewswire Inc.Agenus to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with its TIGIT Bispecific AntibodyNASDAQ:AGENAgenus Inc
10/05/20217:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
10/05/20217:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
10/05/20217:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
10/05/20217:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
10/01/20218:00AMGlobeNewswire Inc.Agenus to Present AGEN1181 Clinical Data at SITCNASDAQ:AGENAgenus Inc
09/16/20216:25PMGlobeNewswire Inc.Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be Presented at ESMONASDAQ:AGENAgenus Inc
09/10/20217:30AMGlobeNewswire Inc.New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo BioworksNASDAQ:AGENAgenus Inc
09/09/20218:00AMGlobeNewswire Inc.Agenus to Participate in September Investor ConferencesNASDAQ:AGENAgenus Inc
08/26/20219:00AMGlobeNewswire Inc.Balstilimab Monotherapy Data Published in Gynecologic OncologyNASDAQ:AGENAgenus Inc
08/09/20217:45AMGlobeNewswire Inc.Agenus Corporate Update and Second Quarter 2021 Financial ReportNASDAQ:AGENAgenus Inc
08/02/20214:05PMGlobeNewswire Inc.Agenus to Participate in the BTIG Virtual Biotechnology Conference 2021NASDAQ:AGENAgenus Inc
07/28/20218:30AMGlobeNewswire Inc.MiNK Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public OfferingNASDAQ:AGENAgenus Inc
07/26/20214:45PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
07/26/20214:05PMGlobeNewswire Inc.Agenus to Provide Corporate Update and Second Quarter 2021 Financial ReportNASDAQ:AGENAgenus Inc
07/07/20214:05PMGlobeNewswire Inc.Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021NASDAQ:AGENAgenus Inc
07/06/20218:30AMGlobeNewswire Inc.Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibod...NASDAQ:AGENAgenus Inc
07/02/20217:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
07/02/20217:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
07/02/20216:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
07/02/20216:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
07/02/20216:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
07/02/20215:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
07/02/20215:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
06/21/20216:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
06/21/20215:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
06/21/20215:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
06/21/20214:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
06/21/20219:00AMGlobeNewswire Inc.Agenus to Participate in the Raymond James 2021 Human Health Innovation ConferenceNASDAQ:AGENAgenus Inc
06/17/20218:30AMGlobeNewswire Inc.Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Re...NASDAQ:AGENAgenus Inc
 Showing the most relevant articles for your search:NASDAQ:AGEN